Contrast Media Market: Billion in 2015 | Radiology
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange

Gold Standard

Radiology Contrast Media Market: $8 Billion in 2015

Contrast Media Market: $8 Billion in 2015

Radiology News - Radiology

The global contrast media market was valued at $5.4 billion in 2008, growing at 5% Compounded Annual Growth Rate (CAGR) to reach $7.9 billion in 2015.

The global market will witness a modest growth due to patent expiry of leading contrast agents such as Myoview and Visipaque in 2010-2011, consequent entry of generics, declining reimbursement and adverse clinical studies associated with contrast agents.

During 2007–2008, patents for leading Magnetic Resonance Imaging ( MRI ) contrast agents such as Omniscan and MutiHance expired. Patents for Myoview and Visipaque are also set to expire in the next one or two years. This has resulted in the emergence of generic contrast media players such as Imaging Agents and has resulted in price reduction.

This trend is expected to continue over the next five years, as more generic players enter the market leading to consequent price reduction. Uncertainty over reimbursement of contrast agents in the future and declining prices are likely to adversely affect the revenues, despite the rise in the number of imaging procedures.

Source: PR-inside

Discuss more about Radiology in our Radiology Group

 

Related Articles